Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)

Clinical trial NCT01482169 · COMPLETED

Trial details

NCT number: NCT01482169
Sponsor: Ochsner Health System
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2012-03-01
Primary completion: 2014-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.